Safety and Efficacy of T89 in Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)
Clinical trial NCT03552263 · COMPLETED
Trial details
- NCT number
- NCT03552263
- Sponsor
- Tasly Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-07
- Primary completion
- 2019-10-20
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.